BioinformaticsbioRxivPreprint
Prioritization of prostate cancer to immune checkpoint therapy by ranking tumors along IFN-γ axis and identification of immune resistance mechanisms
Boris A. Reva, Tatiana Omelchenko, Anna Pamela Calinawan…·Ash Tewari
This study ranks prostate cancer tumors along the IFN-γ/PD-L1 axis to prioritize patients for immune checkpoint therapy and identifies immune resistance mechanisms.
5 citations